Sales Growth YoY (Last 12 Months): IO Biotech, Inc. (IOBT)

Public company logo of IO Biotech Inc. (IOBT)

IO Biotech, Inc. (IOBT) develops immunotherapeutic vaccines while awaiting Phase III melanoma results and potential Big Pharma partnerships. The business's competitiveness is determined solely by the quality of clinical data. Diversification of research programs mitigates overall pipeline risks. The rolling 12-month sales growth rate compared to the previous year demonstrates the correlation between revenue and stock valuation, with the metric currently standing at 0.00.

IO Biotech (IOBT) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 04/18/2026

IO Biotech (IOBT) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Price IO Biotech Inc.|IOBT - Price Target Chart
- company stock exchange capitalization indicators:
Market Capitalization IO Biotech Inc|IOBT - Total Company Value
- balance sheet net asset value indicators:
Net Asset Value per Share IO Biotech|IOBT - Company Net Assets|Market Value to Equity Ratio iobiotech.com|IOBT - Cumulative Company Assets
- debt level and financial liquidity data:
Aggregate Debt to Capital IO Biotech, Inc.|IOBT - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital IO Biotech|IOBT - Company Aggregate Debts|Debts to Book Value IO Biotech Inc|IOBT - Company Long-Term Debt|Company Short-Term Loans and Borrowings IO Biotech|Quick Ratio iobiotech.com
- earnings and market multiples details:
IOBT - Company Net Income|Forward Earnings IO Biotech, Inc.|IOBT - Price to Earnings Ratio|Projected Price to Earnings Ratio IO Biotech, Inc.|IOBT - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio IO Biotech Inc|IOBT - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months IO Biotech|IOBT - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months iobiotech.com|IOBT - Earnings growth in current year|Net earnings per share growth forecast for next year IO Biotech, Inc.
- sales and revenue indicators:
IOBT - Revenue and Sales Volume|Company Future Sales IO Biotech Inc.|IOBT - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio IO Biotech Corp|IOBT - Revenue Growth YoY (Last 12 Months)
Summary company analytics:IO Biotech, Inc.
Product sample of iobiotech.com

IO Biotech, Inc. (IOBT) development of breakthrough vaccines to modify the tumor microenvironment establishes the foundation for scaling commercial operations within the immunotherapy sector. By analyzing the year-over-year revenue growth rate over a 12-month period, investors assess business expansion dynamics by comparing current trailing twelve-month sales with the same period, allowing for an objective determination of the company's growth trajectory and the risk of acquiring the asset at a local peak.

Competitors of IO Biotech, Inc. (IOBT)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|STRO (sutrobio.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) MiNK Therapeutics Inc.|Sales Growth YoY (Last Twelve Months) werewolftx.com (HOWL)|IMMX: Trailing Twelve Months Sales Growth|alxoncology.com - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)